Financial Personal
Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities
HYDERABAD, India, Oct. 28, 2024 (GLOBE NEWSWIRE) — Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], announced that it has received Establishment Inspection Reports (EIR) fro
The General Good Manufacturing Practices (GMP) audit was conducted at the integrated R&D campus (Unit II) in April 2024, while the pre-approval inspection (PAI) & General GMP audit was conducted at the Manufacturing facility (Unit IV) in Bidar in June 2024. Read More
